Trial site
Universitaetsklinikum Brandenburg an der Havel GmbH
- 13running trials
- 5closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis6 trials
- Crohn's disease3 trials
- Chronic kidney disease2 trials
- Eosinophilic oesophagitis2 trials
- Coronary artery disease1 trial
- Gastroparesis1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Liver cirrhosis1 trial
- Ovarian cancer1 trial
- Phase
- Phase 310 trials
- Phase 27 trials
- Phase 41 trial
- Status
- Recruiting9 trials
- Completed5 trials
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- AstraZeneca3 trials
- Merck Sharp & Dohme LLC3 trials
- Abivax S.A.2 trials
- Dr. Falk Pharma GmbH2 trials
- Spyre Therapeutics, Inc.2 trials
- and 6 more
Running trials
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
Recruiting
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis3 recruiting
- Chronic kidney disease2 recruiting
- Crohn's disease2 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Liver cirrhosis1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
Active, not recruiting
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026